Ash Cleary – Associate at LDV Capital

Ash Cleary

Associate

Ash is a graduate of the NYU Stern School of Business, where he concentrated in finance and econometrics. Ash managed equity and fixed-income investment portfolios for New York-based clients and co-founded a B2B SaaS startup called TimeSave (Mint for customer service) during his undergraduate studies. He is an avid reader of current tech, venture capital and economic news. When he is not working, Ash can be found playing Australian football or chess as well as spending time outdoors.

LinkedIn profile »

We are excited to partner with the deep tech team at DANNCE.AI to leverage advanced computer vision solutions to increase drug efficacy and significantly improve the lives of people with movement disorders.

We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

Sustainability is now more important than ever. Meeting the needs of the present without compromising future generations is one of the biggest crises we face as a society. LDV Capital's Evan Nisselson and Ash Cleary cover topics ranging from spectroscopy and nanomaterials to enhance food and agricultural production, to renewable energy forecasting and grid management, and predictive digital twins for the supply chain.

Visual technologies will continue to be the crux of advancements in materials science across nanomaterials and metamaterials, resulting in the transformation of various industrial, medical and consumer applications. Embedded AI will allow materials to self-reconfigure based on their environment. As sensing and algorithms improve, this will revolutionize optics, diagnostics, robotics, 3D printing, and more.

We are thrilled to partner and invest in the Sonus Microsystems team developing and commercializing a novel and proprietary ultrasound technology. Combined with advances in AI, computer vision, and medical image analysis, their advanced transducers unlock new potentials in reliable ultrasound remote monitoring

As the biotech industry relies heavily on data filtering, analysis and sharing, visual technologies will become critical for the detection and imaging of biological systems, paving the way for the future of life sciences tools enabling next-generation therapeutics, biomanufacturing & longevity.

Automation is revolutionizing legacy industries from healthcare and precision medicine to manufacturing and construction, to agriculture and sustainability. The adoption of visual technology innovations will continue to remain the crux of automation for the next decade and beyond.